Advertisement

Trends in Cerebral Embolic Protection Device Use and Association With Stroke Following Transcatheter Aortic Valve Implantation

      Stroke remains a serious complication of transcatheter aortic valve implantation (TAVI). Prior studies examining the association between cerebral embolic protection device (CEPD) use and stroke following TAVI have produced conflicting results. We used the Nationwide Readmissions Databases to identify all percutaneous (non-transapical) TAVIs performed in the US from July, 2017 to December, 2018. Overlap propensity score weighted logistic regression models were used to determine the association between CEPD use and outcomes. The primary outcome was in-hospital stroke or transient ischemic attack (TIA). Among 50,000 percutaneous TAVIs (weighted national estimate: 88,886 [SE: 2,819]), CEPD was used in 2,433 (weighted national estimate: 3,497 [SE: 857]). Nationally, the utilization rate of CEPD was 3.9% (SE: 0.9%) of all TAVIs during the overall study period, which increased from 0.8% (SE: 0.4%) in 2017Q3 to 7.6% (SE: 1.6%) in 2018Q4 (p<0.001). The proportion of hospitals using CEPD increased from 2.3% in 2017Q3 to 14.7% in 2018Q4 (p<0.001). There were no significant differences in rates of in-hospital stroke/TIA in TAVIs with versus without CEPD (2.6% vs 2.2%; unadjusted OR [95% CI] 1.18 [0.98-1.52]; overlap propensity score weighted OR [95% CI] 1.19 [0.81-1.75]). CEPD use was not associated with statistically significant lower rates of in-hospital stroke, ischemic stroke, hemorrhagic stroke, TIA, all-cause mortality, or discharge to skilled nursing facility. In conclusion, the rates of CEPD utilization and proportion of TAVI hospitals using CEPD increased during the study period. The use of CEPD during TAVI was not associated with statistically significant lower rates of in-hospital stroke, TIA, or mortality.

      Graphical abstract

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Huded CP
        • Tuzcu EM
        • Krishnaswamy A
        • Mick SL
        • Kleiman NS
        • Svensson LG
        • Carroll J
        • Thourani VH
        • Kirtane AJ
        • Manandhar P
        • Kosinski AS
        • Vemulapalli S
        • Kapadia SR.
        Association between transcatheter aortic valve replacement and early postprocedural stroke.
        JAMA. 2019; 321: 2306-2315
        • Arnold SV
        • Manandhar P
        • Vemulapalli S
        • Kosinski A
        • Desai ND
        • Bavaria JE
        • Carroll JD
        • Mack MJ
        • Thourani VH
        • Cohen DJ.
        Impact of short-term complications of TAVR on longer-term outcomes: results from the STS/ACC transcatheter valve therapy registry.
        Eur Heart J Qual Care Clin Outcomes. 2020; 7: 208-213
        • Carroll JD
        • Mack MJ
        • Vemulapalli S
        • Herrmann HC
        • Gleason TG
        • Hanzel G
        • Deeb GM
        • Thourani VH
        • Cohen DJ
        • Desai N
        • Kirtane AJ
        • Fitzgerald S
        • Michaels J
        • Krohn C
        • Masoudi FA
        • Brindis RG
        • Bavaria JE.
        STS-ACC TVT registry of transcatheter aortic valve replacement.
        J Am Coll Cardiol. 2020; 76: 2492-2516
        • Vlastra W
        • Jimenez-Quevedo P
        • Tchetche D
        • Chandrasekhar J
        • de Brito Jr., FS
        • Barbanti M
        • Kornowski R
        • Latib A
        • D'Onofrio A
        • Ribichini F
        • Baan J
        • Tijssen JGP
        • De la Torre Hernandez JM
        • Dumonteil N
        • Sarmento-Leite R
        • Sartori S
        • Rosato S
        • Tarantini G
        • Lunardi M
        • Orvin K
        • Pagnesi M
        • Hernandez-Antolin R
        • Modine T
        • Dangas G
        • Mehran R
        • Piek JJ
        • Predictors Delewi R.
        Incidence, and outcomes of patients undergoing transfemoral transcatheter aortic valve implantation complicated by stroke.
        Circ Cardiovasc Interv. 2019; 12e007546
        • Kapadia S
        • Agarwal S
        • Miller DC
        • Webb JG
        • Mack M
        • Ellis S
        • Herrmann HC
        • Pichard AD
        • Tuzcu EM
        • Svensson LG
        • Smith CR
        • Rajeswaran J
        • Ehrlinger J
        • Kodali S
        • Makkar R
        • Thourani VH
        • Blackstone EH
        • Leon MB.
        Insights into timing, risk factors, and outcomes of stroke and transient ischemic attack after transcatheter aortic valve replacement in the PARTNER trial (Placement of Aortic Transcatheter Valves).
        Circ Cardiovasc Interv. 2016; 9e002981
        • Demir OM
        • Iannopollo G
        • Mangieri A
        • Ancona MB
        • Regazzoli D
        • Mitomo S
        • Colombo A
        • Weisz G
        • Latib A.
        The role of cerebral embolic protection devices during transcatheter aortic valve replacement.
        Front Cardiovasc Med. 2018; 5: 150
        • Van Mieghem NM
        • El Faquir N
        • Rahhab Z
        • Rodriguez-Olivares R
        • Wilschut J
        • Ouhlous M
        • Galema TW
        • Geleijnse ML
        • Kappetein AP
        • Schipper ME
        • de Jaegere PP.
        Incidence and predictors of debris embolizing to the brain during transcatheter aortic valve implantation.
        JACC Cardiovasc Interv. 2015; 8: 718-724
        • Kapadia SR
        • Kodali S
        • Makkar R
        • Mehran R
        • Lazar RM
        • Zivadinov R
        • Dwyer MG
        • Jilaihawi H
        • Virmani R
        • Anwaruddin S
        • Thourani VH
        • Nazif T
        • Mangner N
        • Woitek F
        • Krishnaswamy A
        • Mick S
        • Chakravarty T
        • Nakamura M
        • McCabe JM
        • Satler L
        • Zajarias A
        • Szeto WY
        • Svensson L
        • Alu MC
        • White RM
        • Kraemer C
        • Parhizgar A
        • Leon MB
        • Linke A
        • Investigators ST.
        Protection against cerebral embolism during transcatheter aortic valve replacement.
        J Am Coll Cardiol. 2017; 69: 367-377
        • Seeger J
        • Gonska B
        • Otto M
        • Rottbauer W
        • Wohrle J.
        Cerebral embolic protection during transcatheter aortic valve replacement significantly reduces death and stroke compared with unprotected procedures.
        JACC Cardiovasc Interv. 2017; 10: 2297-2303
        • Alkhouli M
        • Alqahtani F
        • Harris AH
        • Hohmann SF
        • Rihal CS.
        Early experience with cerebral embolic protection during transcatheter aortic valve replacement in the United States.
        JAMA Intern Med. 2020; 180: 783-784
        • Megaly M
        • Sorajja P
        • Cavalcante JL
        • Pershad A
        • Gossl M
        • Abraham B
        • Omer M
        • Elbadawi A
        • Garcia S.
        Ischemic stroke with cerebral protection system during transcatheter aortic valve replacement.
        JACC Cardiovasc Interv. 2020; 13: 2149-2155
      1. De Novo Summary (DEN160043) - De Novo Classification Request for Sentinel® Cerebral Protection System. U.S. Food and Drug Administration, 2017. Available at: https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN160043.pdf. Accessed on January 6, 2021.

        • Woodfield R
        • Sudlow CL
        • Grant I, Group UKBSO, Follow-Up UKB, Outcomes Working G
        Accuracy of electronic health record data for identifying stroke cases in large-scale epidemiological studies: a systematic review from the UK Biobank Stroke Outcomes Group.
        PLoS One. 2015; 10e0140533
        • McCormick N
        • Bhole V
        • Lacaille D
        • Avina-Zubieta JA.
        Validity of diagnostic codes for acute stroke in administrative databases: a systematic review.
        PLoS One. 2015; 10e0135834
        • Kokotailo RA
        • Hill MD.
        Coding of stroke and stroke risk factors using international classification of diseases, revisions 9 and 10.
        Stroke. 2005; 36: 1776-1781
        • Hsieh MT
        • Hsieh CY
        • Tsai TT
        • Wang YC
        • Sung SF.
        Performance of ICD-10-CM diagnosis codes for identifying acute ischemic stroke in a national health insurance claims database.
        Clin Epidemiol. 2020; 12: 1007-1013
        • Strom JB
        • Zhao Y
        • Faridi KF
        • Tamez H
        • Butala NM
        • Valsdottir LR
        • Curtis J
        • Brennan JM
        • Shen C
        • Boulware M
        • Popma JJ
        • Yeh RW.
        Comparison of clinical trials and administrative claims to identify stroke among patients undergoing aortic valve replacement: findings from the EXTEND study.
        Circ Cardiovasc Interv. 2019; 12e008231
      2. Yoon F, Sheng M, Jiang HJ, Steiner CA, Barrett ML. Calculating Nationwide Readmissions Database (NRD) Variances. HCUP Methods Series Report # 2017-01. Rockville, MD: U.S. Agency for Healthcare Research and Quality, 2017. June 1, 2021.

        • Thomas LE
        • Li F
        • Pencina MJ.
        Overlap weighting: a propensity score method that mimics attributes of a randomized clinical trial.
        JAMA. 2020; 323: 2417-2418
        • Haussig S
        • Mangner N
        • Dwyer MG
        • Lehmkuhl L
        • Lucke C
        • Woitek F
        • Holzhey DM
        • Mohr FW
        • Gutberlet M
        • Zivadinov R
        • Schuler G
        • Linke A.
        Effect of a cerebral protection device on brain lesions following transcatheter aortic valve implantation in patients with severe aortic stenosis: The CLEAN-TAVI randomized clinical trial.
        JAMA. 2016; 316: 592-601
        • Van Mieghem NM
        • van Gils L
        • Ahmad H
        • van Kesteren F
        • van der Werf HW
        • Brueren G
        • Storm M
        • Lenzen M
        • Daemen J
        • van den Heuvel AF
        • Tonino P
        • Baan J
        • Koudstaal PJ
        • Schipper ME
        • van der Lugt A
        • de Jaegere PP
        Filter-based cerebral embolic protection with transcatheter aortic valve implantation: the randomized MISTRAL-C trial.
        EuroIntervention. 2016; 12: 499-507
        • Kapadia SR.
        Routine use of embolic protection during transcatheter aortic valve replacement.
        JACC Cardiovasc Interv. 2017; 10: 2304-2306
        • Seeger J
        • Kapadia SR
        • Kodali S
        • Linke A
        • Wohrle J
        • Haussig S
        • Makkar R
        • Mehran R
        • Rottbauer W
        • Leon M.
        Rate of peri-procedural stroke observed with cerebral embolic protection during transcatheter aortic valve replacement: a patient-level propensity-matched analysis.
        Eur Heart J. 2019; 40: 1334-1340
        • Butala NM
        • Makkar R
        • Secemsky EA
        • Gallup D
        • Marquis-Gravel G
        • Kosinski AS
        • Vemulapalli S
        • Valle JA
        • Bradley SM
        • Chakravarty T
        • Yeh RW
        • Cohen DJ.
        Cerebral embolic protection and outcomes of transcatheter aortic valve replacement: results from the TVT registry.
        Circulation. 2021; https://doi.org/10.1161/CIRCULATIONAHA.120.052874
        • Nazif TM
        • Moses J
        • Sharma R
        • Dhoble A
        • Rovin J
        • Brown D
        • Horwitz P
        • Makkar R
        • Stoler R
        • Forrest J
        • Messe S
        • Dickerman S
        • Brennan J
        • Zivadinov R
        • Dwyer MG
        • Lansky AJ
        • Investigators RIT.
        Randomized evaluation of TriGuard 3 cerebral embolic protection after transcatheter aortic valve replacement: REFLECT II.
        JACC Cardiovasc Interv. 2021; 14: 515-527
      3. NCT04149535 - PROTECTED TAVR: Stroke PROTECTion With SEntinel During Transcatheter Aortic Valve Replacement (PROTECTED TAVR). ClinicalTrials.gov, 2019. Available at: https://clinicaltrials.gov/ct2/show/NCT04149535. Accessed on January 6, 2021.

      4. ISRCTN16665769 - British Heart Foundation Randomised Trial of Routine Cerebral Embolic Protection in Transcatheter Aortic Valve Implantation (BHF PROTECT-TAVI). International Standard Randomised Controlled Trial Number (ISRCTN), 2020. Available at: https://doi.org/10.1186/ISRCTN16665769. Accessed on January 6, 2021.